Article
Molecular profiling of biliary tract cancer: a target rich disease
1 Oct 2016
Abstract excerpt
Biliary tract cancers (BTCs) are relatively uncommon orphan tumors that have an aggressive disease course and a poor clinical outcome. Surgery is the only curative treatment, but most patients present with advanced disease and therefore have a limited survival. Gemcitabine and cisplatin based chemotherapy has been the only widely accepted standard systemic therapy regimen in these patients but these tumors can be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
